N/A
Completed N=20
"Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program"
Dementia · Alzheimer's Disease · Dementia Prevention
Source: ClinicalTrials.gov NCT05350410 ↗
Enrolled (actual)
20
Serious AEs
—
Results posted
Aug 2024
Primary outcomePrimary: Users' Engagement With the HALT-AD Online Platform by Measuring the Total Amount of Time (in Minutes) Spent Per User on All Courses Combined — 136 minutes
Summary
A Pilot Study for the Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia program (HALT-AD). This initial four-months pilot study will focus on at least three educational courses (introduction to dementia and lifestyle risk factors, sleep and diet). It may also include a fourth educational course on social connectivity and loneliness. Completion of this initial pilot study will allow for a round of improvements informed by data from the program, on usability, as well as feedback from participants and citizen advisors. This will allow for an iterative process to build the program to its full content, with feedback to optimize the user experience and ensure the accessibility of the content. The information generated from this study will help inform the development of the second program's prototype, expected to benefit from the initial pilot to become more user-friendly, effective and accessible to the target audience.
This pilot study will be a longitudinal study of an inception cohort exposed to the HALT-AD online educational program for a four-month study. It will utilize pre- and post- intervention collection of quantitative and qualitative data to evaluate the program's first prototype.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Users' Engagement With the HALT-AD Online Platform by Measuring the Total Amount of Time (in Minutes) Spent Per User on All Courses Combined |
136 | — |
| PRIMARY Users' Engagement With the HALT-AD Online Platform by Measuring the Percentage of Participants Who Completed All Courses. |
10 | — |
| SECONDARY Change From Baseline in Knowledge on the HALT-AD Knowledge Assessment Survey at 4 Months |
1.18 | — |
| SECONDARY Change From Baseline in Self-efficacy on the New General Self-Efficacy Scale (NGSE) at 4 Months. |
0.1 | — |
| SECONDARY Change From Baseline in Lifestyle Risk on the HALT-AD Lifestyle Risk Assessment Survey at 4 Months |
1 | — |
Eligibility Criteria
Inclusion Criteria
- Signed informed consent must be obtained and documented (from the participant).
- Sufficient proficiency in English or Spanish to undergo clinical assessment and participate in an online educational program.
- Ages 50-85
- Montreal Cognitive Assessment-Telephone/Blind Version (T-MoCA) score ≥18/22
- Technical ability to participate in an online educational program (i.e. ability to operate a computer/tablet and gain internet access; ability to send and receive emails)
- Sufficient vision and hearing to participate in online educational program (judgement of site investigator)
- Ability to sit comfortably for a period of at least 30 minutes
Exclusion Criteria
- Participants who, in the opinion of the co-PIs, are not able to complete trial procedures or adhere to the schedule of study assessments will be excluded from study participation.
- Individuals where English or Spanish is not sufficiently proficient for clinical assessment, and participation in a web-based educational program.
- Participants who do not have sufficient vision and hearing to participate in an online educational program
- Individuals who do not have the technical ability to participate in an online educational program. Technical ability is defined as ability to operate a computer/tablet and gain internet access; ability to send and receive emails)
- Total Score on the T-MoCA <18
- Individuals who have an advanced degree (e.g. Master's, MD, PhD) in an area related to brain health will not be eligible to participate.
Data sourced from ClinicalTrials.gov (NCT05350410). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.